Surgical Treatment of Recurrent Shoulder Dislocations
The Arthroscopic Treatment of Anterior Shoulder Instability (ATRASI): A Pilot Multicentre Randomized Controlled Trial
1 other identifier
interventional
200
2 countries
2
Brief Summary
This is a pilot multi-centre, double blinded randomized controlled trial. The primary outcome of this pilot trial will be feasibility. Prior to conducting a large definitive trial, the investigators will conduct this pilot trial comparing arthroscopic Bankart repair with arthroscopic anatomic glenoid reconstruction (AAGR), evaluating recurrent dislocation rates and functional outcomes over a 24-month period. The feasibility objectives are: (1) to evaluate the investigators ability to recruit patients across multiple sites and (2) to assess study protocol adherence and ability to follow patients to 24 months. Clinical objectives for the pilot trial are exploratory only. The investigators wish to gather means and standard deviations for clinical outcomes to power their future definitive trial. The objectives of the definitive trial will include a comparison of patient-reported outcomes at the two-year post-operative time point, differences in recurrence rates, complication rates, functional shoulder assessments, and return to work/sport.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2023
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 15, 2022
CompletedFirst Posted
Study publicly available on registry
October 3, 2022
CompletedStudy Start
First participant enrolled
April 25, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2028
May 4, 2026
April 1, 2026
5.7 years
September 15, 2022
April 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Subject Recruitment
Recruitment of 100 participants
Measured throughout the entire study, up to 2 years
Participant Adherence
Protocol adherence
Measured throughout the entire study, up to 2 years
Patient Follow-up
Proportion of Patients Followed at 24 months
Measured throughout the entire study, up to 2 years
Secondary Outcomes (9)
The Western Ontario Shoulder Instability Index (WOSI)
Measured at 6 month, 1 year, and 2 year time points
American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form
Measured at 6 month, 1 year, and 2 year time points
Disabilities of the Arm, Shoulder, and Hand (DASH)
Measured at 6 month, 1 year, and 2 year time points
MARX Physical Activity Questionnaire
Measured at 6 month, 1 year, and 2 year time points
Quality of Life Assessment (EQ-5D-5L)
Measured at 6 month, 1 year, and 2 year time points
- +4 more secondary outcomes
Study Arms (2)
Bankart Repair
ACTIVE COMPARATORArthroscopic Bankart repair procedures will be performed according to each individual surgeon's usual technique. Procedures will be performed with the patient in the lateral or beach-chair position. Repairs for associated or conjoined superior labral anterior-to-posterior (SLAP) tears will be documented and performed at the surgeon's discretion. Labral detachments will be repaired with the use of suture-anchor fixation and arthroscopic tying techniques. Either two or three suture anchors will be used. Capsular redundancy will be addressed with arthroscopic suture plication at the surgeon's discretion. Surgeons will mobilize the capsulolabral tissue as deemed necessary. Surgical time and video of the operation will be recorded, and photographs will be taken documenting any bone loss.
Anatomic Glenoid Reconstruction
EXPERIMENTALThe surgical technique was the lateral decubitus all-arthroscopic anatomic glenoid reconstruction procedure for treatment of anterior shoulder instability as described by Wong et al. (2015). The procedure is done in a semi-lateral decubitus position that assists with optimal graft placement on the native glenoid. The investigators utilize the cannulated Bristow-Latarjet Instability Shoulder System (Depuy-Mitek, MA, USA). The surgical technique is identical to that of arthroscopic Bankart repair with one additional step. Prior to insertion of anchors, one additional medal portal is created for insertion of the bone graft. The distal tibia allograft is prepared; the cannulated guide is attached and advanced through the rotator interval and secured with two cannulated screws. Finally, the Bankart repair is performed above the graft. Surgical time and video of the operation will be recorded, and photographs will be taken documenting any bone loss.
Interventions
Patients Randomized to Bankart Repair Group
Patients Randomized to Anatomic Glenoid Reconstruction Group
Eligibility Criteria
You may qualify if:
- Recurrent anterior glenohumeral dislocation (two or more incidents)
- Presence of glenoid and/or humerus bone loss on imaging (x Ray, CT or MRI)
You may not qualify if:
- Uncontrolled diabetes (Hgb A1C \>7%)
- Prior surgery of affected shoulder
- Pregnancy
- Multidirectional instability
- Posterior instability
- Paralysis of the shoulder
- Cancer
- Severe systemic illness
- Presence of massive rotator cuff tear
- Patients that present with \< 10% or \> 25% bone loss under preoperative imaging.
- Generalized laxity (\>5/9 Beighton Score)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The Hawkins Foundationcollaborator
- Nova Scotia Health Authoritylead
- Canadian Institutes of Health Research (CIHR)collaborator
- NYU Langone Healthcollaborator
- Panam Cliniccollaborator
- Vancouver Coastal Healthcollaborator
- University of British Columbiacollaborator
- Ottawa Hospital Research Institutecollaborator
- Children's Hospital of Eastern Ontario Research Institutecollaborator
- Horizon Health Networkcollaborator
- Research St. Joseph's - Hamiltoncollaborator
- London Health Sciences Centre Research Institutecollaborator
- University of Utahcollaborator
- Orlando Health, Inc.collaborator
- TSAOG Orthopaedics and Spinecollaborator
Study Sites (2)
NYU Langone Health
New York, New York, 10016, United States
Nova Scotia Health Authority
Halifax, Nova Scotia, B3H 2E1, Canada
Study Officials
- PRINCIPAL INVESTIGATOR
Ivan H Wong, MD
Nova Scotia Health Authority
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 15, 2022
First Posted
October 3, 2022
Study Start
April 25, 2023
Primary Completion (Estimated)
December 31, 2028
Study Completion (Estimated)
December 31, 2028
Last Updated
May 4, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share